FeesSafety
Pluang+

UniCredit set for major growth with Commerzbank acquisition and strong 2024 profit outlook

Market News
04 Nov 2026, 08:49 WIB
Seeking Alpha
View Source
Bullish
UniCredit set for major growth with Commerzbank acquisition and strong 2024 profit outlook

UniCredit is expanding significantly through its planned acquisition of Commerzbank, having secured ECB approval and expecting to gain a controlling stake this year. The bank posted record second-quarter and half-year results, with a 5% increase in core revenues and improved efficiency shown by a 34% cost/income ratio. Management forecasts net profits exceeding €11 billion in 2024, rising to €15 billion by 2030, with the Commerzbank deal expected to add further value. Despite higher valuation multiples, UniCredit trades at a forward P/E of 9.11x and offers a 4.49% dividend yield, suggesting the shares remain undervalued and attractive to investors.

UniCredit's expansion through acquisition is notable. For readers following the Financials sector, here is Pluang's market snapshot as of Nov 04, 2026 14:01 WIB: Among 142 priced US Financials stocks, 32 rose and 109 fell. Key movers include HUT at USD 61.81 with a 3.04% decline and 80% buy order activity, BN at USD 40.21 down 3.01%, and SMFG at USD 23.33 down 2.83%.

More News

STMicroelectronics launches unified STM32 MCU platform for industrial, automotive, and AI applications.

STMicroelectronics launches unified STM32 MCU platform for industrial, automotive, and AI applications.

STMicroelectronics announced a unified STM32 microcontroller platform that spans industrial, automotive, and robotics applications, enabling developers to reuse architectures, software, and tools across these sectors. The new STM32A family extends th...

Market News
Bullish
1 hour ago
dsm-firmenich reports 5% sales growth and margin expansion in Q3 2026, raising full-year sales outlook to 5%.

dsm-firmenich reports 5% sales growth and margin expansion in Q3 2026, raising full-year sales outlook to 5%.

dsm-firmenich announced a strong Q3 2026 trading update with 5% like-for-like sales growth and an improved Adjusted EBITDA margin of 20.4%. The company’s performance was driven by volume growth across its three business units: Perfumery & Beauty, Tas...

Company Fundamentals
Bullish
1 hour ago
Solvay reports Q3 2026 sales down 3.3% amid Middle East conflict, advances rare earths strategy with Viridis deal.

Solvay reports Q3 2026 sales down 3.3% amid Middle East conflict, advances rare earths strategy with Viridis deal.

Solvay's Q3 2026 underlying net sales fell 3.3% organically to €1,031 million, impacted by the Middle East conflict and weak soda ash markets. EBITDA dropped 26.6% organically to €173 million, partly due to a €25 million impact from the conflict and ...

Company Fundamentals
Bearish
1 hour ago
Milestone Pharmaceuticals grants 33,000 stock options to new employee under Nasdaq inducement rule.

Milestone Pharmaceuticals grants 33,000 stock options to new employee under Nasdaq inducement rule.

Milestone Pharmaceuticals announced the grant of 33,000 stock options to a newly hired employee as an inducement under Nasdaq Listing Rule 5635(c)(4). The options, priced at $0.72 each, will vest over four years with a one-year cliff and monthly inst...

Company Fundamentals
Neutral
5 hours ago
Bitcoin spot volume dips in October despite price rise above $85,000, with options and futures open interest high.

Bitcoin spot volume dips in October despite price rise above $85,000, with options and futures open interest high.

In October, Bitcoin's daily spot trading volume averaged about $6.8 billion early in the month but showed signs of weakening demand by late October, despite the price rising above $85,000. Options and futures open interest remained substantial, rangi...

Market News
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App